Pharmaceuticals South Africa

South Africa Single-Cell Analysis Market Analysis, 2024–2034

South Africa Single-Cell Analysis Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

South Africa · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $37.5 Mn Estimated value
Estimate 2025 $43.6 Mn 0.7% of the global market
Projected 2034 $168.4 Mn 286.2% Adds $124.8 Mn over 9 forecast years
CAGR 2025–2034 16.2% Faster than 75% of 180 Pharmaceuticals markets here
Key players 5
  • South Africa is 0.73% of the global market.
  • In Africa, the largest is South Africa (this report) at $43.6 Mn.
  • Fastest growing: Egypt at 16.8% a year.
  • South Africa ranks 1st of 3 by size in Africa.

Market size projection

South Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$124.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Single-Cell Analysis Market market size by year, South Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $37.5 Mn — —
2025 (base) $43.6 Mn +$6.1 Mn —
2026 (forecast) $50.7 Mn +$7.1 Mn +16.2%
2027 (forecast) $58.9 Mn +$8.2 Mn +35%
2028 (forecast) $68.4 Mn +$9.5 Mn +56.9%
2029 (forecast) $79.5 Mn +$11.1 Mn +82.3%
2030 (forecast) $92.4 Mn +$12.9 Mn +111.9%
2031 (forecast) $107.4 Mn +$15.0 Mn +146.2%
2032 (forecast) $124.8 Mn +$17.4 Mn +186.1%
2033 (forecast) $145.0 Mn +$20.2 Mn +232.4%
2034 (forecast) $168.4 Mn +$23.5 Mn +286.2%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $5.95 Bn
  2. North America $2.54 Bn
  3. US $2.11 Bn
  4. Europe $1.22 Bn
  5. APAC $1.24 Bn
  6. Canada $526.7 Mn
  7. China $490.4 Mn
  8. Japan $388.7 Mn
  9. Latin America $275.8 Mn
  10. Germany $238.9 Mn
  11. Middle East $205.9 Mn
  12. UK $159.2 Mn
  13. France $149.8 Mn
  14. Italy $140.5 Mn
  15. Brazil $142.5 Mn
  16. Spain $121.8 Mn
  17. India $130.3 Mn
  18. Ecuador $103.2 Mn
  19. Mexico $94.2 Mn
  20. Africa $94.8 Mn
  21. Saudi Arabia $88.6 Mn
  22. New Zealand $65.7 Mn
  23. Australia $65.9 Mn
  24. Russia $54.4 Mn
  25. South Africa (this report) $43.6 Mn
  26. UAE $31.8 Mn
  27. Egypt $19.2 Mn
  28. Philippines $11.3 Mn
  29. Hong Kong $10.3 Mn
  30. Malaysia $8.4 Mn
  31. Thailand $7.8 Mn
  32. Singapore $6.4 Mn
  33. Kenya $4.5 Mn

The South Africa Single-Cell Analysis Market Analysis Executive Summary

Single-cell analysis studies DNA, RNA or proteins in individual cells, showing differences hidden in bulk samples.

Key segments of the single-Cell Analysis market include product (Instruments, Consumables and Software) and application (Cancer Research, Immunology and Stem Cells).

South Africa Single-Cell Analysis Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the single-Cell Analysis market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the single-Cell Analysis market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the single-Cell Analysis market.

Competitive Landscape for Single-Cell Analysis Market in South Africa

The single-Cell Analysis market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Single-Cell Analysis Market in South Africa

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for single-Cell Analysis. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in South Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Single-Cell Analysis right now, from free public sources.

Latest research 6,521 papers since 2021 (worldwide)

  1. Multi-omics and pharmacological analyses identify DDX60 as a candidate EGCG-engaged target in esophageal squamous cell carcinoma. European journal of pharmacology, 2026
  2. CONCLAVE: A consensus clustering with annotation-validation extrapolation for cyclic multiplexed immunofluorescence data. Cell reports methods, 2026
  3. Single-cell analysis of chromatin state and transcriptome in the human basal ganglia. Cell, 2026
  4. Solution-processed Ti(3)C(2)T(x) MXene coatings for three-dimensional microelectrodes in label-free single-cell impedance spectroscopy. iScience, 2026
  5. Integrative bulk and single-cell transcriptomics links amino acid metabolism-related biomarkers to endothelial immune remodeling in periodontitis. Frontiers in immunology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Single-Cell Analysis in context

South Africa compared

  • Health spending per person: 537 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in Africa.[1]
  • Doctors: 0.79 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in Africa.[2]
  • People aged 65 and over: 6.9% of people (2025). World: 10.4% of people (2025). 2nd highest of the 17 countries we cover in Africa.[3]

Questions, answered with public data

How much research is published on Single-Cell Analysis?
PubMed lists 6,521 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Single-Cell Analysis in South Africa? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in South Africa

See all
Same topic, other categories

Related on genomics

See the topic